GR3032191T3 - Use of antioxidative steroids for the manufacture of pharmaceutical preparations for substition therapy in man - Google Patents

Use of antioxidative steroids for the manufacture of pharmaceutical preparations for substition therapy in man

Info

Publication number
GR3032191T3
GR3032191T3 GR990403277T GR990403277T GR3032191T3 GR 3032191 T3 GR3032191 T3 GR 3032191T3 GR 990403277 T GR990403277 T GR 990403277T GR 990403277 T GR990403277 T GR 990403277T GR 3032191 T3 GR3032191 T3 GR 3032191T3
Authority
GR
Greece
Prior art keywords
substition
antioxidative
steroids
man
therapy
Prior art date
Application number
GR990403277T
Other languages
English (en)
Inventor
Michael Prof Dr Oettel
Wolfgang Prof Dr Roemer
Doris Dr Huebler
Jens Schroeder
Sigfrid Prof Dr Schwarz
Peter Dr Droescher
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of GR3032191T3 publication Critical patent/GR3032191T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
GR990403277T 1995-07-08 1999-12-17 Use of antioxidative steroids for the manufacture of pharmaceutical preparations for substition therapy in man GR3032191T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19524937A DE19524937A1 (de) 1995-07-08 1995-07-08 Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen und zur medikamentösen Substitution beim Mann

Publications (1)

Publication Number Publication Date
GR3032191T3 true GR3032191T3 (en) 2000-04-27

Family

ID=7766353

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990403277T GR3032191T3 (en) 1995-07-08 1999-12-17 Use of antioxidative steroids for the manufacture of pharmaceutical preparations for substition therapy in man

Country Status (7)

Country Link
EP (1) EP0753300B1 (el)
JP (1) JP2765822B2 (el)
AT (1) ATE184795T1 (el)
DE (2) DE19524937A1 (el)
DK (1) DK0753300T3 (el)
ES (1) ES2138272T3 (el)
GR (1) GR3032191T3 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877169A (en) * 1993-11-05 1999-03-02 University Of Florida Research Foundation, Inc. Methods of treatment of ischemic damage
AU739071C (en) * 1998-02-20 2002-04-11 Jenapharm Gmbh & Co. Kg Pharmaceutical preparations for the selectively supplementing estrogen deficiency in the central nervous system
DE19821831A1 (de) * 1998-05-15 1999-11-18 Jenapharm Gmbh Pharmazeutische Präparate zur gezielten Substitution des Estrogenmangels im Zentralnervensystem
US6245756B1 (en) 1998-02-27 2001-06-12 Jenapharm Gmbh & Co. Kg Pharmaceutical preparations for treatment of estrogen deficiency in the central nervous system
DE19915576A1 (de) * 1999-03-30 2000-10-05 Jenapharm Gmbh Equileninderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US6339078B1 (en) 1999-07-20 2002-01-15 University Of Florida Research Foundation, Inc. Methods of prevention and treatment of ischemic damage
US6326365B1 (en) 1999-07-20 2001-12-04 Apollo Biopharmaceutics, Inc. Methods of prevention and treatment of ischemic damage
US6559177B2 (en) 2001-04-19 2003-05-06 Wyeth 5, 11-Dioxa-benzo[b]fluoren-10-one and 5-oxa-11-thia-benzo[b]fluoren-10-ones as estrogenic agents
US6589980B2 (en) 2001-05-17 2003-07-08 Wyeth Substituted 10,11-benzo[b]fluoren-10-ones as estrogenic agents
AU2005247948A1 (en) 2004-05-27 2005-12-08 Migenix Corp. 2-substituted 17-imino estrogen compounds for cytoprotection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626061A (en) * 1967-09-08 1971-12-07 Upjohn Co Compositions comprising 7{60 -methyl-17{60 -lkylated estradiols
IL107343A (en) * 1992-11-02 2003-10-31 Wyeth Corp PHARMACEUTICAL COMPOSITION FOR LOWERING BLOOD LIPID LEVEL, COMPRISING, 17alpha-DIHYDROEQUILENIN
DE4338314C1 (de) * 1993-11-10 1995-03-30 Jenapharm Gmbh Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen

Also Published As

Publication number Publication date
EP0753300B1 (de) 1999-09-22
JP2765822B2 (ja) 1998-06-18
JPH09100292A (ja) 1997-04-15
EP0753300A1 (de) 1997-01-15
ATE184795T1 (de) 1999-10-15
DE59603130D1 (de) 1999-10-28
ES2138272T3 (es) 2000-01-01
DK0753300T3 (da) 2000-03-27
DE19524937A1 (de) 1997-01-09

Similar Documents

Publication Publication Date Title
EP0746202A4 (en) COMPOSITION CONTAINING A PHARMACEUTICALLY ACTIVE ANTI-OXIDANT AND METHOD FOR USE IN THE PREVENTION AND TREATMENT OF RESTENOSIS AFTER ANGIOPLASTY
MX9703694A (es) Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel.
CA2181742A1 (en) Reduction of skin irritation during electrotransport delivery
AU4859793A (en) Sulfated ligands for l-selectins and use of chlorates and or sulfatases for the treatment of inflammation
ZA791797B (en) Use of antioestrogens and antigonadotropically active antiandrogens for the prophylaxis and therapy of prostate hyperplasia
EP0147261A3 (en) Medicine and medicinal composition for the treatment and the prevention of skin affections involving an inflammation process
CA2069483A1 (en) Steroid sulphatase inhibitors
CA2116562A1 (en) Morphogen-Induced Modulation of Inflammatory Response
AU3459689A (en) Treatment of skin disorders
GR3031691T3 (en) Composition and method for preventing and treating inflammation with immunoglobulin a
GR3032191T3 (en) Use of antioxidative steroids for the manufacture of pharmaceutical preparations for substition therapy in man
GB9226832D0 (en) Pharmaceutical preparations for the treatment of psoriasis
AU626033B2 (en) Methods for the treatment and prophylaxis of pneumocystis carinii pneumonia and other diseases and compounds and formulations for use in said methods
AU5743194A (en) Treatment of dermatological malignancies with biologically active peptides
HU904007D0 (en) Medical preparations providing regulated active agent discharge and processes for the preparation thereof
HU9402816D0 (en) Medicament for the treatment of airways inflammation and airways hyperresponsiveness
HU9501641D0 (en) Transdermal administration systhm containig acetylsalicylic acid for antithromboitc therapy and the preventio of cancer
HU910109D0 (en) Process for the production of medical preparations for preventing proline-and lysine-hydroxylase and process for the production of some of the active agents
AU3569193A (en) The use of 7-oxo-7H-pyrido (1,2,3-de) (1,4) benzoxazine-6-carboxylic acids and esters as medicaments
AU3764689A (en) Use of local anaesthetic agents in the manufacture of preparations with wound healing effect
AU3039789A (en) Active substance for treating changes in the skin and mucous membranes
CA2088588A1 (en) Treatment of hair loss and dermatological problems
AU3053595A (en) Therapeutic treatment and preparations
Richards Topical and systemic treatment of psoriasis: Part 2
AU7885998A (en) Use of cis- or transurocamic acid for the treatment of photodermatoses and immunogenic skin diseases